Metraipolis › archive › dc_641c9099330c

Post Hoc Subgroup Analysis by Disease Severity in a Non-Inferiority Trial of Donepezil 27.5 mg Transdermal Formulation in Japanese Patients With… — Europe PMC PMID:42411945

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42411945
DOI: 10.1097/wad.0000000000000738
License (as archived): solo-consultazione
Archived: 2026-10-23T15:17:08.257Z
SHA-256 of the archived text: 81ba264d12a8b86e1addbc1da0423b81e29bc90afeacba8291d793a99a7c5bc0
Stable URL of this page: https://metraipolis.com/documento/dc_641c9099330c

How to cite

Post Hoc Subgroup Analysis by Disease Severity in a Non-Inferiority Trial of Donepezil 27.5 mg Transdermal Formulation in Japanese Patients With… — Europe PMC PMID:42411945 — Europe PMC (en), https://europepmc.org/article/MED/42411945 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_641c9099330c (Metraipolis archive dc_641c9099330c, sha256 81ba264d12a8b86e1addbc1da0423b81e29bc90afeacba8291d793a99a7c5bc0)

BibTeX

@misc{dc641c9099330c,
  title = {Post Hoc Subgroup Analysis by Disease Severity in a Non-Inferiority Trial of Donepezil 27.5 mg Transdermal Formulation in Japanese Patients With… — Europe PMC PMID:42411945},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42411945},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_641c9099330c; sha256 81ba264d12a8b86e1addbc1da0423b81e29bc90afeacba8291d793a99a7c5bc0},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42411945. Agents can read the archived copy with the MCP tool read_document.